Your search returned 2 results.

Results
	1.	Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma. [electronic resource] by Ludwig, Heinz Kasparu, Hedwig Leitgeb, Clemens Rauch, Elisabeth Linkesch, Werner Zojer, Niklas Greil, Richard Seebacher, Adelheid Pour, Ludek Weißmann, Adalbert Adam, Zdenek Producer: 20140421 In: Blood vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas. [electronic resource] by Brämswig, Kira Ploner, Ferdinand Martel, Alexandra Bauernhofer, Thomas Hilbe, Wolfgang Kühr, Thomas Leitgeb, Clemens Mlineritsch, Brigitte Petzer, Andreas Seebacher, Veronika Stöger, Herbert Girschikofsky, Michael Hochreiner, Gerhard Ressler, Sigrun Romeder, Franz Wöll, Ewald Brodowicz, Thomas Producer: 20150129 In: Anti-cancer drugs vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search